The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid) has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for amlodipine besylate tablets, 2.5 mg, 5 mg and 10 mg.
With this approval, Orchid's cumulative ANDA approval count stands at 32 and the total ANDA filing count stands at 58.